Friday, 19th April
Register
Log in
Password recovery
Menu
COVID-19
Alzheimer’s & Dementia
Cancer
Diabetes
Heart & Lung
Infection
Men’s
Women’s
Mental
Muscular
Surgery
Innovation
Sexual Health
Paediatrics
Lifestyle
NHS
Medico-Legal
Neurodiversity
Reproductive Health
Nutrition
Aesthetic
CPD
Global Reach
Drugs
[esi adrotate group="1" cache="private" ttl="0"]
Karen Aiach
About
Latest Posts
Karen Aiach
Karen Aiach is CEO and founder of Lysogene, a biotech company developing gene therapy for central nervous system disorders.
Latest posts by Karen Aiach
(
see all
)
Gene therapy for nervous system disorders
- 16th April 2017
Gene therapy for nervous system disorders
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
OK
Read more